Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 15:59
Elite Pharmaceuticals Shareholders Equity (Quarterly): 47.27M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 47.27M |
June 30, 2024 | 58.25M |
March 31, 2024 | 57.58M |
December 31, 2023 | 46.41M |
September 30, 2023 | 45.09M |
June 30, 2023 | 30.12M |
March 31, 2023 | 28.96M |
December 31, 2022 | 30.17M |
September 30, 2022 | 27.19M |
June 30, 2022 | 25.53M |
March 31, 2022 | 25.22M |
December 31, 2021 | 22.79M |
September 30, 2021 | 20.50M |
June 30, 2021 | 18.70M |
March 31, 2021 | 16.15M |
December 31, 2020 | 16.63M |
September 30, 2020 | 14.62M |
June 30, 2020 | 11.79M |
March 31, 2020 | 10.66M |
December 31, 2019 | 9.080M |
September 30, 2019 | 10.85M |
June 30, 2019 | 12.04M |
March 31, 2019 | -2.508M |
December 31, 2018 | 13.64M |
September 30, 2018 | 15.67M |
Date | Value |
---|---|
June 30, 2018 | 16.99M |
March 31, 2018 | 18.48M |
December 31, 2017 | 19.89M |
September 30, 2017 | 20.09M |
June 30, 2017 | 17.68M |
March 31, 2017 | 25.66M |
December 31, 2016 | 26.05M |
September 30, 2016 | 22.48M |
June 30, 2016 | 15.54M |
March 31, 2016 | 11.16M |
December 31, 2015 | -2.069M |
September 30, 2015 | 12.49M |
June 30, 2015 | -15.32M |
March 31, 2015 | 0.2689M |
December 31, 2014 | -30.54M |
September 30, 2014 | -55.36M |
June 30, 2014 | -84.45M |
March 31, 2014 | -81.20M |
December 31, 2013 | -4.927M |
September 30, 2013 | -5.852M |
June 30, 2013 | -6.400M |
March 31, 2013 | -8.673M |
December 31, 2012 | -12.36M |
September 30, 2012 | -21.80M |
June 30, 2012 | -23.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
9.080M
Minimum
Dec 2019
58.25M
Maximum
Jun 2024
28.14M
Average
25.38M
Median
Shareholders Equity (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 5.413B |
BioCardia Inc | 2.753M |
Zevra Therapeutics Inc | 69.77M |
Verrica Pharmaceuticals Inc | -34.05M |
Terns Pharmaceuticals Inc | 364.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 88.20M |
Total Liabilities (Quarterly) | 40.93M |
Debt to Equity Ratio | 0.1575 |
Current Ratio | 3.524 |
Net Debt Paydown Yield | 0.02% |